|
|
||||||||
Endocrinology and Metabolism |
a Author for correspondence. Fax 44-171-606-5937.
The determination of glycohemoglobin [HbA1c,
HbA1, or total glycohemoglobin (GHb)] has become an
established procedure in the management of diabetes mellitus. Here, we
describe the development of a simple, fluorescence, non-separation
assay for the percentage of GHb (%GHb). The fluorescence of an
eosin-boronic acid derivative when it was mixed with hemolysates of
unwashed erythrocytes was quenched in proportion to the percentage of
glycohemoglobin. Measurement of the fluorescence intensity gave an
estimate of GHb in the sample, and measurement of light absorbance gave
an estimate of total hemoglobin. A combination of the two measurements
gave the assay response. Comparison with HPLC (Menarini-Arkray HA-8140
fully automated analyzer) for the percentage of HbA1
(%HbA1) gave %GHb(NETRIA) = 1.1(SD
±0.03)%HbA1 +0.6(SD ±0.3), Sy
x
= 0.821, r = 0.972, n = 80; comparison for
HbA1c gave %GHb(NETRIA) = 1.3(SD
±0.04)%HbA1c + 1.8(SD ±0.3),
Sy
x = 0.813, r = 0.973,
n = 80. Precision, estimated as the percentage of the CV of the
%GHb assay results, was <2% (intraassay, range 522% GHb) and
<4.2% (interassay, range 416% GHb). Dilution of a high-percentage
GHb sample lysate showed that the assay was linear, and addition of
glucose (60 mmol/L), bilirubin (250 µmol/L), and triglycerides (14
mmol/L) to low, medium, and high %GHb samples showed no clinical
interference in assay results.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |